Shandong Pharmaceutical Glass Co (SHSE:600529) Total Liabilities : ¥1,834 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shandong Pharmaceutical Glass Co Total Liabilities?

Shandong Pharmaceutical Glass Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,834 Mil.

Shandong Pharmaceutical Glass Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,643.88 Mil) to Dec. 2023 (¥1,784.21 Mil) and increased from Dec. 2023 (¥1,784.21 Mil) to Mar. 2024 (¥1,833.60 Mil).

Shandong Pharmaceutical Glass Co's annual Total Liabilities increased from Dec. 2021 (¥1,739.41 Mil) to Dec. 2022 (¥1,822.57 Mil) but then declined from Dec. 2022 (¥1,822.57 Mil) to Dec. 2023 (¥1,784.21 Mil).

Shandong Pharmaceutical Glass Co Total Liabilities Historical Data

The historical data trend for Shandong Pharmaceutical Glass Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Pharmaceutical Glass Co Total Liabilities Chart

Shandong Pharmaceutical Glass Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,302.50

1,365.53

1,739.41

1,822.57

1,784.21

Shandong Pharmaceutical Glass Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,802.25	1,921.30	1,643.88	1,784.21	1,833.60

Shandong Pharmaceutical Glass Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shandong Pharmaceutical Glass Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1726.592	+	(0	+	57.621
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,784

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	9318.722	-	7534.509
	=	1,784

Shandong Pharmaceutical Glass Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1763.513	+	(0	+	70.09
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,834

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	9588.071	-	7754.469
	=	1,834

Shandong Pharmaceutical Glass Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shandong Pharmaceutical Glass Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Pharmaceutical Glass Co (SHSE:600529) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Shandong Pharmaceutical Glass Co Ltd (SHSE:600529) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yaobo Road, Yiyuan County, Zibo, Shandong, CHN, 256100

Website

http://www.pharmglass.com

Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.

Shandong Pharmaceutical Glass Co (SHSE:600529) Headlines

No Headlines